Trial
NCT04640025
A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
—
Condition
Myelofibrosis
Intervention
itacitinib
Why stopped
The decision to close the study was made due to the expiration of remaining drug supply.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-26